Endogenous vascular and immune signaling partners

The term "Endogenous vascular and immune signaling partners" does not refer to a single specific molecular target, such as a unique receptor or enzyme. Instead, it describes a complex functional network of naturally occurring molecules—including cytokines, chemokines, growth factors (like VEGF and Angiopoietins), and their respective receptors—that coordinate the physiological interactions between the circulatory and immune systems. These signaling partners are critical for maintaining vascular integrity, regulating blood flow, and directing leukocyte trafficking during inflammatory responses. In various disease states, such as oncology or chronic inflammation, the balance of these signaling pathways is often disrupted, leading to pathological angiogenesis or immune evasion. Because this term encompasses a wide array of distinct proteins and pathways, it is considered too broad to serve as a canonical therapeutic target name for drug development or regulatory purposes.

Other names

Vascular-immune signaling networkNeurovascular-immune signaling components

Not applicable as this is a broad descriptive category rather than a single molecular entity.